Segall Bryant & Hamill’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.35M Sell
27,213
-1,281
-4% -$197K 0.06% 318
2025
Q4
$3.91M Sell
28,494
-890
-3% -$115K 0.05% 338
2025
Q3
$3.57M Sell
29,384
-1,953
-6% -$211K 0.05% 344
2025
Q2
$3.35M Sell
31,337
-2,434
-7% -$243K 0.05% 360
2025
Q1
$3.13M Sell
33,771
-711
-2% -$68.9K 0.05% 370
2024
Q4
$3.71M Sell
34,482
-2,435
-7% -$296K 0.05% 375
2024
Q3
$4.64M Buy
36,917
+516
+1% +$64.9K 0.06% 344
2024
Q2
$3.95M Buy
+36,401
New +$3.55M 0.07% 325

Other funds holding NHC

Segall Bryant & Hamill's NHC Position: Q1 2026 in Review

Segall Bryant & Hamill reduced its National Healthcare (NHC) stake by 4.5% in Q1 2026, selling an estimated $197K and leaving 27,213 shares worth $4.35M. The position accounts for 0.06% of the portfolio, ranked #318.

Segall Bryant & Hamill first reported a position in NHC in Q2 2024 and has held it in 8 quarters since. The position peaked at $4.64M in Q3 2024. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.

  • Segall Bryant & Hamill held 27,213 shares of National Healthcare worth $4.35M as of Q1 2026.
  • Segall Bryant & Hamill sold 1,281 National Healthcare shares in Q1 2026, an estimated $197K.
  • National Healthcare made up 0.06% of Segall Bryant & Hamill's portfolio in Q1 2026, its #318 holding.
  • Segall Bryant & Hamill first reported a position in National Healthcare in Q2 2024 and has held it in 8 quarters since.
  • Segall Bryant & Hamill's National Healthcare position peaked at $4.64M in Q3 2024.
  • 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.

Based on Segall Bryant & Hamill's 13F filing for Q1 2026, filed 15 May 2026.